Figure 4

Reduction of P-Ser473 Akt by gemcitabine (dFdC) and pemetrexed (MTA) in bladder cancer cell lines T24 and J82. *P<0.05 with respect to control.
Reduction of P-Ser473 Akt by gemcitabine (dFdC) and pemetrexed (MTA) in bladder cancer cell lines T24 and J82. *P<0.05 with respect to control.